BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19656404)

  • 21. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR signaling controls lethal encephalitis in WNV-infected brain.
    Sabouri AH; Marcondes MC; Flynn C; Berger M; Xiao N; Fox HS; Sarvetnick NE
    Brain Res; 2014 Jul; 1574():84-95. PubMed ID: 24928618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
    Yanagibashi T; Nagai Y; Watanabe Y; Ikutani M; Hirai Y; Takatsu K
    Immunol Lett; 2015 Jan; 163(1):22-31. PubMed ID: 25448706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
    Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
    Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
    Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
    Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.
    Lichtnekert J; Vielhauer V; Zecher D; Kulkarni OP; Clauss S; Segerer S; Hornung V; Mayadas TN; Beutler B; Akira S; Anders HJ
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F867-74. PubMed ID: 19158348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TIR-domain-containing adapter inducing interferon-β-dependent signaling cascade plays a crucial role in ischemia-reperfusion-induced retinal injury, whereas the contribution of the myeloid differentiation primary response 88-dependent signaling cascade is not as pivotal.
    Dvoriantchikova G; Santos AR; Danek D; Dvoriantchikova X; Ivanov D
    Eur J Neurosci; 2014 Aug; 40(3):2502-12. PubMed ID: 24754835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
    Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
    J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
    Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
    Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells.
    Lee HY; Takeshita T; Shimada J; Akopyan A; Woo JI; Pan H; Moon SK; Andalibi A; Park RK; Kang SH; Kang SS; Gellibolian R; Lim DJ
    BMC Infect Dis; 2008 Jun; 8():87. PubMed ID: 18578886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
    Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
    Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.
    Liu G; Zhai X; Zhou H; Yang X; Zhang N; Tai G; Ni W
    Cell Immunol; 2018 Mar; 325():56-63. PubMed ID: 29452695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
    Buchholz BM; Billiar TR; Bauer AJ
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF)-Dependent Antiviral Responses Protect Mice against Ross River Virus Disease.
    Liu X; Taylor A; Poo YS; Ng WH; Herrero LJ; Tang PCH; Zaid A; Mahalingam S
    mBio; 2022 Feb; 13(1):e0336321. PubMed ID: 35089088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
    Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MyD88 signaling inhibits protective immunity to the gastrointestinal helminth parasite Heligmosomoides polygyrus.
    Reynolds LA; Harcus Y; Smith KA; Webb LM; Hewitson JP; Ross EA; Brown S; Uematsu S; Akira S; Gray D; Gray M; MacDonald AS; Cunningham AF; Maizels RM
    J Immunol; 2014 Sep; 193(6):2984-93. PubMed ID: 25114104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles.
    Pearl JI; Ma T; Irani AR; Huang Z; Robinson WH; Smith RL; Goodman SB
    Biomaterials; 2011 Aug; 32(24):5535-42. PubMed ID: 21592562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.